Nkarta, Inc. (NKTX) Financials

NKTX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 372.1 million 86.2 million
Dec. 31, 2025 404.2 million 91.9 million
Sept. 30, 2025 427.2 million 89.3 million
June 30, 2025 448.3 million 90.6 million

NKTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -28.6 million 1.9 million
Dec. 31, 2025 -22.2 million 1.9 million
Sept. 30, 2025 -18.7 million 1.8 million
June 30, 2025 -18.9 million 2.1 million

NKTX Net Income

No data available :(

NKTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 230.4 million 67.9 million 75.0 million
Dec. 31, 2025 276.3 million - 69.5 million
Sept. 30, 2025 282.3 million - 76.6 million
June 30, 2025 289.7 million - 78.5 million

NKTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 74.3 million
Dec. 31, 2025 74.0 million
Sept. 30, 2025 74.0 million
June 30, 2025 74.0 million

NKTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 413000 22.6 million 5.9 million -
Dec. 31, 2025 560000 25.3 million 5.7 million -
Sept. 30, 2025 8000 20.2 million 7.1 million -
June 30, 2025 138000 20.8 million 6.4 million -

NKTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 2.3 million
Dec. 31, 2025 - 2.3 million
Sept. 30, 2025 - -
June 30, 2025 - 2.3 million

NKTX

Price: $2.62

52 week price:
1.63
3.65

Earnings Per Share: -1.35 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 296100

Market Capitalization: 194.6 million

Links: